Subcutaneous apomorphine in patients with advanced Parkinson's disease: A dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single dose

Journal of the Neurological Sciences ◽

10.1016/j.jns.2007.03.013 ◽

2007 ◽

Vol 258 (1-2) ◽

pp. 137-143 ◽

Author(s):

Rajesh Pahwa ◽

William C. Koller ◽

Richard M. Trosch ◽

James H. Sherry

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Single Dose ◽

Dose Escalation ◽

Dose Escalation Study ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Double Blind Placebo ◽

Subcutaneous Apomorphine

Download Full-text

A randomised, double-blind, placebo-controlled, dose-escalation study of multiple doses of BIIB014 administered orally in subjects with early Parkinson's disease

http://isrctn.org/> ◽

10.1186/isrctn55858075 ◽

2013 ◽

Author(s):

Stefan Gagaouzov

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Dose Escalation ◽

Dose Escalation Study ◽

Double Blind ◽

Double Blind Placebo ◽

Multiple Doses ◽

Early Parkinson’S Disease

Download Full-text

A randomised, double-blind, placebo-controlled, dose escalation study of single and multiple oral dose administration of BIIB014 in subjects with moderate to late stage parkinson's disease who are also receiving treatment with levodopa

http://isrctn.org/> ◽

10.1186/isrctn12870393 ◽

2013 ◽

Author(s):

David J Brooks

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Oral Dose ◽

Dose Escalation ◽

Dose Escalation Study ◽

Double Blind ◽

Dose Administration ◽

Double Blind Placebo ◽

Multiple Oral Dose

Download Full-text

Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study

Journal of Neurology Neurosurgery & Psychiatry ◽

10.1136/jnnp.66.4.436 ◽

1999 ◽

Vol 66 (4) ◽

pp. 436-441 ◽

Author(s):

M M Pinter ◽

O Pogarell ◽

W H Oertel

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Multicentre Study ◽

Dopamine Agonist ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Double Blind Placebo

Download Full-text

Clinical evaluation of pramipexole in advanced Parkinson's disease: Results of a double-blind, placebo-controlled, parallel-group study

Neurology ◽

10.1212/wnl.49.1.162 ◽

1997 ◽

Vol 49 (1) ◽

pp. 162-168 ◽

Author(s):

A. Lieberman ◽

A. Ranhosky ◽

D. Korts

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Clinical Evaluation ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Download Full-text

Intravenous flumazenil for Parkinson's disease: A single dose, double blind, placebo controlled, cross-over trial

Movement Disorders ◽

10.1002/mds.21022 ◽

2006 ◽

Vol 21 (10) ◽

pp. 1614-1617 ◽

Author(s):

William G. Ondo ◽

Yavuz S. Silay

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Single Dose ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Safety and pharmacokinetics of PF-04360365 following a single-dose intravenous infusion in Japanese subjects with mild-to-moderate Alzheimerâs disease: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation study

International Journal of Clinical Pharmacology and Therapeutics ◽

10.5414/cp201816 ◽

2013 ◽

Vol 51 (12) ◽

pp. 911-923 ◽

Author(s):

Izuru Miyoshi ◽

Yoko Fujimoto ◽

Masahito Yamada ◽

Sadahiro Abe ◽

Qinying Zhao ◽

...

Keyword(s):

Single Dose ◽

Dose Escalation ◽

Intravenous Infusion ◽

Dose Escalation Study ◽

Double Blind ◽

Double Blind Placebo ◽

Japanese Subjects

Download Full-text

A double-blind, placebo-controlled, randomized, multi-center study of pramipexole in advanced Parkinson's disease

European Journal of Neurology ◽

10.1046/j.1468-1331.1998.530235.x ◽

1998 ◽

Vol 5 (3) ◽

pp. 235-242 ◽

Author(s):

L. Wermuth ◽

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Double Blind Placebo ◽

Multi Center Study ◽

Download Full-text

Phase I, randomized, double-blind, placebo-controlled, single-dose escalation study of the recombinant factor VIIa variant BAY 86-6150 in hemophilia

Journal of Thrombosis and Haemostasis ◽

10.1111/j.1538-7836.2012.04667.x ◽

2012 ◽

Vol 10 (5) ◽

pp. 773-780 ◽

Author(s):

J. N. MAHLANGU ◽

M. J. COETZEE ◽

M. LAFFAN ◽

J. WINDYGA ◽

T. T. YEE ◽

...

Keyword(s):

Single Dose ◽

Phase I ◽

Dose Escalation ◽

Recombinant Factor Viia ◽

Factor Viia ◽

Dose Escalation Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Rotigotine transdermal patch in Chinese patients with advanced Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study

Parkinsonism & Related Disorders ◽

10.1016/j.parkreldis.2017.08.015 ◽

2017 ◽

Vol 44 ◽

pp. 6-12 ◽

Author(s):

Zhen-Xin Zhang ◽

Chun-Feng Liu ◽

En-Xiang Tao ◽

Ming Shao ◽

Yi-Ming Liu ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Chinese Patients ◽

Transdermal Patch ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Double Blind Placebo ◽

Pivotal Study ◽

Rotigotine Transdermal Patch

Download Full-text

Transdermal rotigotine in advanced Parkinson’s disease: a randomized, double-blind, placebo-controlled trial

Journal of Neurology ◽

10.1007/s00415-014-7427-3 ◽

2014 ◽

Vol 261 (10) ◽

pp. 1887-1893 ◽

Author(s):

Masahiro Nomoto ◽

Yoshikuni Mizuno ◽

Tomoyoshi Kondo ◽

Kazuko Hasegawa ◽

Miho Murata ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Trial ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Double Blind Placebo

Download Full-text